Abstract. Previous studies have demonstrated that the expression levels of cytokines are increased in degenerated intervertebral disc tissues, and several cytokines are associated with the pathogenesis of intervertebral disc degeneration. However, the role of interleukin (IL)-2 in the cellular functions of intervertebral disc tissues remains unreported. The present study aimed to determine the expression levels of IL-2 in the nucleus pulposus (NP) tissues of patients with a prolapsed lumbar intervertebral disc; and to observe the changes in cell proliferation, apoptosis, extracellular matrix (ECM) metabolism and p38 mitogen-activated protein kinase (MAPK) signaling in human NP cells (HNPCs) following treatment with IL-2. The present study demonstrated that IL-2 expression levels were upregulated in the NP tissues of patients with a prolapsed lumbar intervertebral disc; and a subsequent MTT assay demonstrated that IL-2 inhibits the proliferation of HNPCs in a dose-dependent manner. Furthermore, as demonstrated by the increased protein expression levels of Fas cell surface death receptor and the induction of caspase-8 and caspase-3 activity, the death receptor pathway was activated by IL-2 in the HNPCs in order to promote cell apoptosis. In addition, IL-2 promoted ECM degradation in the HNPCs, as demonstrated by an increase in the expression levels of type I collagen, a disintegrin and metalloproteinase with thrombospondin motifs and matrix metalloproteinases, and decreased aggrecan and type II collagen expression levels. Furthermore, phosphorylated-p38 was significantly increased in the HNPCs following IL-2 treatment. In conclusion, the present study demonstrated that IL-2 inhibits cell proliferation, and induces cell apoptosis and ECM degradation, accompanied by the activation of p38 MAPK signaling in HNPCs. Therefore, IL-2 may be a potential therapeutic agent for the treatment of degenerative disc disease.
Introduction
The prolapse of a lumbar intervertebral disc is a common ailment that places pressure on the surrounding nerves and causes pain in the waist and leg. Intervertebral disc degeneration (IDD) has been demonstrated to be the main cause of lumbar intervertebral disc prolapse. Approximately 20% of teenage indiciduals have discs with mild signs of degeneration, while ~10% of 50-year-old individuals and ~60% of 70-year-old individuals posses discs that exhibit severe degeneration (1) . However, the pathogenesis of IDD is associated with various cellular and biochemical alterations (2) . IDD is associated with numerous risk factors, including lifestyle, co-morbidities, genetic predisposition and age (3) .
Previous studies have detected high expression levels of cytokines in degenerated intervertebral disc tissues, including interleukin (IL)-1, interferon (IFN)-γ and tumor necrosis factor (TNF)-α, and these cytokines are associated with the pathogenesis of IDD (4-6).
IL-2, which is a pleiotropic cytokine primarily produced by T lymphocytes, has been implicated in the development and control of inflammatory disease (7, 8) . A previous study demonstrated that IL-2 mRNA expression was downregulated in the epidural compartment following intervertebral disc extrusion (9) , and IL-2 expression levels in the disc samples of patients with lumbar degenerative disc disease were significantly increased, as compared with the controls (10) . These findings suggested that IL-2 may be associated with intervertebral disc disease; however, the role of IL-2 in the cellular functions of intervertebral disc tissues remains unclear.
In the present study, the expression levels of IL-2 in the nucleus pulposus (NP) tissues, the avascular and aneural tissues in the center of the intervertebral disc, of patients with prolapsed lumbar intervertebral discs were investigated, and in Interleukin-2 is upregulated in patients with a prolapsed lumbar intervertebral disc and modulates cell proliferation, apoptosis and extracellular matrix metabolism of human nucleus pulposus cells Briefly, the cells were washed and lysed prior to incubation of the supernatant with acetyl-Asp-Glu-Val-Asp p-nitroanilide and N-Acetyl-Ile-Glu-Thr-Asp-p-nitroanilide, respectively. The release of p-nitroaniline was determined by measuring the absorbance at 405 nm using a SpectraMax 190 microplate reading (Molecular Devices, LLC, Sunnyvale, CA, USA). The caspase activities were expressed as a percentage, relative to the control.
Reverse transcription-quantitative polymerase chain reac tion (RT-qPCR).
Tissues were homogenized using the Dounce tissue grinder. Total RNA was harvested from the NP tissues or the HNPCs using TRIzol ® reagent (Invitrogen; Thermo Fisher Scientific Inc.), and subsequently reverse transcribed into cDNA using a First Strand cDNA Synthesis kit (Fermentas; Thermo Fisher Scientific Inc.), according to the manufacturer's instructions. The primers for RT-qPCR are outlined in Table I . PCR amplification was performed with 2 ng cDNA using a 7300 Sequence Detection system (Applied Biosystems; Thermo Fisher Scientific, Inc.) with a SYBR ® Green PCR kit (Applied Biosystems; Thermo Fisher Scientific, Inc.). The cycling conditions were as follows: 5 min at 95˚C, followed by 42 cycles of 5 min at 95˚C, 15 sec at 58˚C and 10 sec at 72˚C, finally 10 min at 95˚C. Relative mRNA expression levels were calcu lated using the 2 -ΔΔCq 
Results

IL-2 expression levels are increased in patients with a
prolapsed lumbar intervertebral disc. In order to determine the expression levels of IL-2 in the NP tissues, NP tissues were collected from the patients and controls as outlined, prior to RT-qPCR and ELISA analyses. IL-2 mRNA expression levels were significantly increased in the NP tissues of patients with a prolapsed lumbar intervertebral disc, as compared with the controls (P<0.01; Fig. 1 ). Furthermore, IL-2 protein expression levels were significantly increased in the NP tissues of patients with a prolapsed lumbar intervertebral disc (P<0.05; Fig. 2 ).
IL-2 inhibits the proliferation of HNPCs in a dose-dependent manner.
To investigate the effects of IL-2 on the proliferation of HNPCs, the cells were treated with various concentration of IL-2 (1, 5, 10 and 20 ng/ml), and an MTT assay was performed. As demonstrated in Fig. 3 , IL-2 inhibited the proliferation of the HNPCs in a dose-dependent manner. No significant effects on the viability of the HNPCs were observed at the lowest IL-2 concentration (1 ng/ml); however, 5, 10 and 20 ng/ml IL-2 significantly decreased the viability of the HNPCs. 
IL-2 significantly increases the expression levels of apoptosis-related proteins in
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and -8 were analyzed in the HNPCs, using commercial kits. As demonstrated in Fig. 4 , IL-2 significantly increased (P<0.05) the protein expression levels of Fas in the HNPCs; and the activities of caspase-3 and -8 were also increased in the HPNCs following treatment with IL-2 ( Fig. 5A and B) 
IL-2 affects ECM metabolism in HNPCs.
HNPCs were treated with 20 ng/ml IL-2 for 24 h, and the mRNA expression levels of: Aggrecan; type I and type II collagen; ADAMTS-4 and -5; and MMP-3 and -13 were analyzed using RT-qPCR. As outlined in Fig. 6A , the mRNA expression levels of aggrecan were reduced by 58% following treatment with IL-2 in the HNPCs. Furthermore, following IL-2 administration, a 1.33-fold increase in the mRNA expression levels of type I collagen was detected; however, type II collagen mRNA expression levels were significantly decreased (P<0.05). Furthermore, IL-2 treatment significantly increased (P<0.05) the mRNA expression levels of ADAMTS-4 and -5, and MMP-3 and -13 (Fig. 6B) .
The protein expression levels of: Aggrecan; type I and type II collagen; ADAMTS-4 and -5; and MMP-3 and -13 were examined by western blot analysis. Similar to the mRNA expression level results, IL-2 significantly increased (P<0.05) the protein expression levels of type I collagen, ADAMTS-4 and -5, MMP-3 and -13, whereas the protein expression levels of aggrecan and type II collagen were decreased ( Fig. 7 and 8 ).
IL-2 induces the phosphorylation of p38 in HNPCs.
The expression levels of p38 and its phosphorylated form were examined in the HNPCs following treatment with IL-2. As outlined in Fig. 9 , the protein expression levels of p38 were not altered in response to IL-2 treatment; however, IL-2 successfully induced the phosphorylation of p38 in the HNPCs. The expression of phosphorylated-p38 protein was significantly upregulated in IL-2-treated HNPCs, as compared with the untreated control cells (P<0.05).
Discussion
The intervertebral disc contains a central NP encapsulated by endplates and the annulus fibrosus (12) . The NP is an avascular and aneural tissue capable of resisting compressive loads, which acts as a pump in order to regulate the flow of liquids and gases in the disc. Therefore, the NP has a significant influence on the overall function and homeostasis of the intervertebral disc (13) . In the present study, human NP tissues from patients presenting with a prolapsed lumbar intervertebral disc were harvested and the mRNA and protein expression levels of IL-2 were analyzed. The results demonstrated that IL-2 was highly upregulated in the NP tissues of patients with a prolapsed lumbar intervertebral disc, as compared with the control patients. These results suggested that IL-2 may have a pathogenic role in the prolapse of lumbar intervertebral discs.
Previous studies have demonstrated that the expression levels of cytokines, including IL-1, IL-17 and TNF-α, are elevated in pathological disc tissue, and they increase in line with the grade of degeneration (6, 14) . These cytokines interact with a large genetic program that is instrumental in maintaining the appropriate homeostasis of cells within the intervertebral disc. A previous in vivo study demonstrated that IL-2 is upregulated in patients with a prolapsed lumbar intervertebral disc (4); however, the mechanisms underlying the association between IL-2 and IDD have yet to be elucidated. In the present study, in order to further understand the role of IL-2 in the pathophysiological mechanisms associated with disc degeneration, in vitro experiments were performed to determine the effects of IL-2 on apoptosis, ECM metabolism and the proliferation of HNPCs.
In the present study, the HNPCs were cultured and treated with various concentrations of IL-2. An MTT assay demonstrated that IL-2 inhibits the proliferation of HNPCs in a dose-dependent manner, and 20 ng/ml IL-2 was determined to be the optimal concentration for the inhibition of HNPCs. Furthermore, 20 ng/ml IL-2 was applied to investigate the effect of IL-2 on the apoptosis and ECM metabolism of HNPCs.
The NP of the intervertebral disc contains a proteoglycan-rich ECM, which normally functions to retain water (15, 16) ; however, degenerated intervertebral discs lose their normal architecture, leading to alterations in cell shape and biochemical characteristics. The role of apoptosis and apoptosis-related genes in the development of degenerative diseases has garnered much attention in recent years. The excessive apoptosis of NP cells, which are capable of producing ECM components, is one of the most discernable cellular and biochemical changes credited to degeneration (17) (18) (19) (20) (21) (22) . A previous study demonstrated that NP cells predominantly undergo apoptosis via the death receptor pathway, which contributes to degeneration of the intervertebral disc (23) . The death receptor pathway is initiated by the binding of cell surface receptors, such as Fas, which activates initiator caspases, primarily caspase-8, which in turn activate effector caspases, predominantly caspase-3 (24) . In the present study, IL-2 induced the expression of Fas protein and increased the activities of caspase-3 and -8 in the HNPCs, thus suggesting that the death receptor pathway may be activated by IL-2 in HNPCs in order to promote cell apoptosis.
NP cells secrete a complex ECM comprised mainly of type II collagen and proteoglycans (25) . Disc degeneration results from an imbalance between the degradation and synthesis of ECM components. Alterations in collagen type, and a decrease in proteoglycan content may cause dehydration and desiccation within the NP, and the intervertebral disc may be come a more fibrotic and less cartilaginous structure (26-29) as a result. Aggrecan is a large proteoglycan that forms aggregates, the loss of which is considered to be an early biochemical abnormality of IDD (30) . Previous studies have demonstrated that destructive enzymes, such as MMPs or ADAMTS, are upregulated in NP cells, leading to the downregulation of aggrecan and collagen type II (31) (32) (33) (34) (35) . In order to elucidate the effects of IL-2 on ECM metabolism in the HNPCs, the expression levels of degrading enzymes that have been demonstrated to hydrolyze aggrecan and collagen were measured. RT-qPCR and western blot analysis demonstrated that the expression levels of ADAMTS-4 and -5, and MMP-3 and -13 were significantly increased following treatment with IL-2. In addition, aggrecan expression levels were significantly decreased, and collagen was altered from type II to I. These findings suggested that IL-2 may promote ECM degradation in HNPCs.
Studer et al (36) demonstrated that the p38 MAPK signaling pathway is a potential target for the treatment of IDD. NP cells respond to inflammatory cytokines via p38 MAPK; therefore, inhibition of p38 MAPK signaling may decrease the factors that negatively affect the metabolic balance and viability of NP cells. In the present study, phosphorylated-p38 was significantly upregulated following IL-2 treatment, suggesting that IL-2 may activate p38 MAPK signaling in HNPCs.
In conclusion, the expression of IL-2 was significantly upregulated in the NP tissues of patients with a prolapsed lumbar intervertebral disc. In addition, the present study demonstrated that IL-2 inhibits cell proliferation, induces cell apoptosis and ECM degradation, and activates p38 MAPK signaling in HNPCs. These findings provide a novel insight into the molecular pathogenesis of IDD.
